Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples